Health Condition 1: O- Medical and Surgical Health Condition 2: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients scheduled to undergo diagnostic endoscopic ultrasonography 2)American society of Anaesthesiologist (ASA)physical status I to III 3)Body Mass Index (BMI) ranging from 18.5 to 22.9
Exclusion criteria
Exclusion criteria: 1)Patients not willing to participate in the study 2) known allergy to propofol or Dexmeditomidine 3) history of long term opioid use or alcohol abuse 4) history of significant Psychiatric illness 5)patients with severe pulmonary, cardiac and renal disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the dose of Propofol required for sedation between two groupsTimepoint: Base line vitals Dose of propofol bolus given throughout the procedure dose of total Dexmeditomidine given | — |
Secondary
| Measure | Time frame |
|---|---|
| Recovery time from sedation between two groups Haemodynamic changes associated with intravenous infusion of DexmeditomidineTimepoint: Base line vitals vitals every 5minutes from time of Dexmeditomidine bolus dose for 10minutes vitals every 5minutes from time of Dexmeditomidine infusion till end of procedure. recovery time from sedation using Modified Observers Assessment of Alertness & Sedation scale | — |
Countries
India
Contacts
kasturba medical college, Mangalore